AGEMAL (IP: Pedro Luis Alonso)
Immune mechanisms against malaria acquired naturally in the new-born.

The most ambitious biomedical research projects cross borders, and the model promoted by the European Commission is one of the most attractive ones in the international scene. In recent years, IDIBAPS has played a growing role in European biomedical research. Currently, its researchers coordinate more than 10 projects financed by the European Commission and take part in nearly 50 more, all obtained through competitive tenders. This makes IDIBAPS and Barcelona an important focal point of European biomedical research.

Immune mechanisms against malaria acquired naturally in the new-born.

Study on adipose tissue in obesity: crosstalk in beta cells.

Measures to combat damage caused by alcohol consumption

Genomics and phenotypes in chronic diseases: computer tools for clinical practice

Mid- and long-term monitoring of live donors: psychological well-being, quality of life and impact of the donating process.

Improving clinical care of patients with rare congenital and acquired anaemias

Common European framework for guaranteeing the health and safety of living organ donors

Provision of multidisciplinary clinical and basic training in Foetal Medicine

Non-invasive tool for analysing 100 mutations and predicting the progress of patients with IBD

Evaluation of new strategies for integrated, innovative care in chronic patients

Characterising the epidemiology and clinical treatment of malaria caused by P. Vivax during pregnancy

Novel approaches based on bionanoscience to manipulate, study, visualize and dissociate the nucleocapsid complex of HIV

New three-dimensional tool based on ultrasound for evaluating volume in different organs

Translational Research on Combating Antimicrobial Resistance

Translational Research on genomic predictors and oncogenic drivers in hepatocellular carcinoma